AtriCure
ATRC
211 hedge funds and large institutions have $1.99B invested in AtriCure in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 73 increasing their positions, 80 reducing their positions, and 27 closing their positions.
22% more call options, than puts
Call options by funds: $1.63M | Put options by funds: $1.33M
16% more capital invested
Capital invested by funds: $1.72B → $1.99B (+$271M)
0.53% more ownership
Funds ownership: 96.18% → 96.71% (+0.53%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 27
9% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 80
1% less funds holding
Funds holding: 214 → 211 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$55.2M |
| 2 |
Millennium Management
New York
|
+$31.3M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.35M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$6.76M |
| 5 |
BlackRock
New York
|
+$6.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$23.9M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$23.2M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$20.2M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$9.07M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$7.1M |
ATRC Hedge Fund Activity: Q4 2022 in Review
211 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2022, worth a combined $1.99B — up 16% from $1.72B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of ATRC and 25 opened new positions — a net loss of 2 holders — while 80 trimmed existing stakes and 73 added.
The largest buyer was Wellington Management Group, adding an estimated $55.2M. The largest seller was Fred Alger Management, cutting an estimated $23.9M.
- 211 institutional investors held AtriCure (ATRC) as of Q4 2022, down from 214 in Q3 2022.
- Funds reported $1.99B of AtriCure stock for Q4 2022, up 16% quarter-over-quarter.
- 25 funds opened new AtriCure positions in Q4 2022 and 27 closed out, a net change of -2 holders.
- The largest AtriCure buyer in Q4 2022 was Wellington Management Group, an estimated $55.2M added.
- The largest AtriCure seller in Q4 2022 was Fred Alger Management, an estimated $23.9M sold.
Based on aggregated 13F filings for Q4 2022.